Roche and Labroots are pleased to announce the first-ever global DISCOVERY user symposium. This year long event will run from November 2020 to November 2021 and will focus on advancements in tissue research. This event is a peer-to-peer meeting, allowing you to hear from fellow researchers about their work with the DISCOVERY product portfolio.
Register Now to access the following content on demand:
DISCOVERY products are for research use only. Not for use in diagnostic procedures.
Thierry P.P. van den Bosch is a postdoctoral researcher for 3 years at the Erasmus University Medical Center, Rotterdam. In 2014 he graduated from the University of applied science in Leiden specialized as pathology technician. In 2018 he finished his PhD at the Erasmus University Medical Center on the subject: Monocytes and Macrophages in Solid Organ Transplantation. After finishing his PhD, he joined the department of Pathology – PARTS (Pathology and Research Trial Service) where he optimizes and introduces new technologies within the field of pathology and support scientists on specific scientific questions, especially in the field of chromogenic and immunofluorescent multiplexing.
Nelson Alexander received his Ph.D. in Cancer Biology from the University of Arizona, followed by a post-doctoral fellowship at Vanderbilt University. Looking to have a more direct impact on patient care, he joined Roche Tissue Diagnostics (RTD) in 2007 where he has held multiple roles in R&D, as well as Research & Early Development. During his time at RTD Nelson became very interested in the interface between tumor heterogeneity and sampling bias. Nelson currently lead a research team within Roche Sequencing Solutions that is pioneering a new sampling process that enables the evaluation and quantification of tumor diversity at the genomic, transcriptomic, and cellular levels from entire solid tumors.
Srabani Bhaumik is a Staff Scientist in the Strategic Applications and Innovation Lab at Roche Tissue Diagnostics. Her R&D experiences includes molecular imaging, molecular pathology, small animal imaging, MRI contrast media imaging, reporter gene imaging, regenerative medicine and in-vitro assay development in oncology. Her current work is focused on fluorescent multiplexing (mIF) assay development on Roche automated IHC/ISH instruments, image acquisition and image analysis on multiple platforms. She was the technical lead for the development and launch of the fluorescent RUO 5-Plex assay on Roche Discovery platform. She has successfully developed complex fluorescent multiplex assays on various oncology samples including 3D cell spheroids and cytology. Prior to Roche, she worked at General Electric Global Research, where she focused on the MultiOmyx platform to explore immune oncology biomarker.
Sara Eglitis is a former scientist at NovoVita Histopath Laboratory, a CRO in Boston, MA specializing in a wide ranging of histopathology services including immunohistochemistry and digital image analysis. She is now Laboratory Director at StageBio.
Charalambos Solomides began his career in medicine at the Rheinishe Friedrich-Wilhelms University of Bonn, Germany, where he attended Medical School. Following graduation in 1988 with a Degree in Medicine he successfully completed his medical doctorate thesis in 1991, and graduated from the same university with a Doctorate of Medicine (Dr. Med.). Following 2 years in clinical research at Albany Medical College in NY, USA (1991-1993), he enrolled in the Residency Pathology Program of Temple University Hospital (TUH) in Philadelphia (1993). He completed his Residency in Pathology in 1998 and a Fellowship in Cytopathology 1999 at Thomas Jefferson University. He joined the faculty at TUH, Department of Pathology in 1999 as Assistant and later as Associate Professor of Pathology and Director of Cytopathology (2004). In 2009 he joined the Department of Pathology at Thomas Jefferson University Hospital in Philadelphia where is currently The Warren R. Lang Professor of Pathology, Anatomy and Cell Biology and Director of Cytopathology and the Immunohistochemistry Lab. His special interest is in Cytopathology and Lung Pathology. Charalambos has published over 70 publications in peer reviewed journals and 2 book chapters.
Faruk Erdem Kombak is a research associate in Memorial Sloan Kettering Cancer Center, New York. He has been working in Precision Pathology Biobanking Center of this institution since September 2019. He was born in Turkey, in 1986 and completed his medical degree in Istanbul University, Turkey, in 2010. He finished his anatomical pathology residency in Marmara University, Turkey, in 2016. He worked as attending pathologist in Turkey for 3 years. In his current position; he performs histological and immunohistochemical assessment for clinical trials/scientific projects as well as multiplex immunohistochemistry and tissue microarray construction.
Vivian Barry is a Senior Scientist in the Pathobiology group at Gilead Sciences. She began her career in molecular biology and immunology research areas at DNAX and Genentech. She eventually ventured into histopathology research and became the manager of the immunohistochemistry team at Arresto Biosciences in 2008. Vivian joined Gilead in 2011, with the acquisition of Arresto, and has been managing the IHC/Pathology group at Gilead since that time. Over the years, she has focused on building the histopathology lab and has introduced various machinery and techniques to enhance the delivery of high quality IHC and CISH data. Her team focuses on target validation in both human tissues and animal models, assists in determining mechanism of action of therapeutics and small molecules, and is involved in IND-enabling studies. She collaborates with investigators across Gilead’s departments; these projects include virology, immunology, oncology, and fibrotic diseases. Vivian received her Bachelor of Science and Master of Science degrees at the University of San Francisco, and has recently received her MBA from the Golden Gate University, San Francisco.
Mr. Hellewell has been with Roche Tissue Diagnostics (RTD) for 8 years where he has held several positions within the company. He began his career with RTD UK where he held sales and applications positions. In 2016 he relocated to Tucson, AZ to take up a global role with customer support for RTD. In 2017 he joined the DISCOVERY International Business team as Global Reagent and Training Lead, where he manages their reagent portfolio and global DISCOVERY training activities for customers and RTD personnel.
The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|
- For viewing Webinars:
- For viewing Virtual Events